2018 Events
American Academy of Ophthalmology Annual Meeting 2018
Randomized, Prospective, Double-Masked Controlled Phase 2b Trial on the Safety & Efficacy of Risuteganib (Luminate) for DME
Presented by Peter K. Kaiser, MD
October 29, 2018
McCormick Place, Chicago
OIS@AAO 2018
Risuteganib for the Treatment of DME
Presented by Vicken Karageozian, MD, President & CEO
October 25, 2018
Marriott Marquis Chicago
18th EURETINA Congress
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema (DME)
Presented by Pravin Dugel, MD
September 20, 2018
The Reed Messe Center, Vienna, Austria
American Society of Retina Specialists (ASRS) Annual Meeting 2018
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Presented by Peter K. Kaiser, MD
July 24, 2018
Vancouver Convention Center, Vancouver, Canada
OIS RETINA 2018
Risuteganib (Luminate®) for the Treatment of DME
Presented by Vicken Karageozian, MD, President & CMO, Allegro Ophthalmics
July 20, 2018
Four Seasons, Vancouver, Canada
OCTANe Ophthalmology Technology Summit
Risuteganib (Luminate®) Potential Paradigm Shift for Broad Spectrum Treatment of Diabetic Macular Edema
Presented by Vicken Karageozian, MD, President & CMO, Allegro Ophthalmics
June 29, 2018
Newport Beach, CA
2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Effects of Anti-VEGF and ALG-1001 on Human Retinal Cells In Vitro
Special Interest Group: Managing Patients with Diabetic Macular Edema, Diabetic Retinopathy, Neovascular and Non-Neovascular AMD, and Retinal Vein Occlusion: How to Best Utillize the Latest Data from Clinical Trials
Faculty includes Peter Campochiaro, Judy Kim, Robert Avery, David Boyer, Diana Do, and Quan Dong Nguyen
April 30, 2018
Honolulu, Hawaii
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate) in Diabetic Macular Edema
Presented by Hugo Quiroz-Mercado, MD
April 30, 2018
Honolulu, Hawaii
Presented by Cristina Kenney, MD, PhD
April 29, 2018
Honolulu, Hawaii
ISOPT Clinical 2018
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate) in DME
Presented by Baruch D. Kuppermann, MD, PhD
March 1, 2018
Tel-Aviv, Israel
Angiogenesis, Exudation, and Degeneration 2018
Integrin Antagonism and Diabetic Macular Edema
Presented by Peter K. Kaiser, MD
February 10, 2018
Miami, FL
Hawaiian Eye & Retina 2018
Prospective, Double-Masked, Placebo-Controlled Phase 2b Trial on the Safety and Efficacy of ALG-1001 (Luminate) in DME
Presented by Peter K. Kaiser, MD
January 17, 2018
Maui, Hawaii
